Company Analysis
Sign in

AnaptysBio, Inc. (ANAB)

Nasdaq: ANAB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2006
Full chart Alerts Compare
Grade6.4
◀ Past 6.1● Present 6.3▶ Future 6.7
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Filings

331 filings since 2017 beside 365 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Feb 14, 2027
10-KT Annual report, transition period for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Sep 28, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Jun 29, 2026.

Filings a yearinsider forms included
50456753518589113
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest May 11, 2026.SEC letters: 2 in the last 36 months, the newest Nov 13, 2024.
Insider forms 365

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 21, 2026 10-KT Annual report, transition period Jun 30, 2026
Sep 21, 2026 8-K item 9.01 Financial statements and exhibits · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 11, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report
Jul 30, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report Jul 28, 2026
Jun 29, 2026 ARS Annual report to shareholders Dec 31, 2025
Jun 29, 2026 DEFA14A Extra proxy material
Jun 29, 2026 DEF 14A Proxy statement
Jun 22, 2026 8-K item 1.01 Major agreement signed · Current report Jun 15, 2026
May 29, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
May 21, 2026 8-K item 5.03 Charter, bylaw or fiscal-year change · Current report May 18, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 15, 2026 SCHEDULE 13G Large holder notice
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 8-K items 2.02, 9.01 Results released · Current report
May 11, 2026 8-K item 5.02 Officer or director change · Current report
Apr 28, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 24, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Apr 20, 2026
Apr 20, 2026 8-K items 1.01, 2.01, 5.02, 8.01, 9.01 Major agreement signed; Purchase or sale of a business completed; Officer or director change; Other event · Current report
Mar 27, 2026 8-K items 1.01, 1.02, 5.02, 7.01, 9.01 Major agreement signed; Major agreement ended; Officer or director change; Investor disclosure (Regulation FD) · Current report Mar 26, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 3, 2026 10-K Annual report Dec 31, 2025
Mar 3, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 11, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 16, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 9, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 26, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 21, 2025 8-K items 8.01, 9.01 Other event · Current report
Nov 21, 2025 8-K item 8.01 Other event · Current report Nov 20, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 12, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 10, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 4, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 14, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 29, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 23, 2025 SCHEDULE 13G Large holder notice
Aug 7, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 331 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ANAB · research, not advice